Patent ID: 11918642
Assignee: ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 6:
7. The method of claim 1, wherein the vaccinia VLP is isolated from a mammalian cell transfected with at least one replicating but highly attenuated vaccinia virus vector selected from the group consisting of:
a first replicating but highly attenuated vaccinia virus vector comprising a third nucleic acid sequence encoding Gag,
a second replicating but highly attenuated vaccinia virus vector comprising a fourth nucleic acid sequence encoding a fragment of gp41, and
a third replicating but highly attenuated vaccinia virus vector comprising the third nucleic acid sequence encoding Gag and the fourth nucleic acid sequence encoding fragment of gp41.